There are of course both sides when it comes to many medications on the market today, according to the study and the way in which the study words the information. This has been seen in practically every study of every drug on the market today. The only true way to receive adequate truth about a clinical study or research is to read more than one study and combine the information in an effort to find the true meanings. Some studies are designed to create false hope while others are designed to disprove a remarkable find according to the motive behind the study.
Dwarfism & Children
With the human growth hormone, many children with dwarfism have been using human growth hormone therapy for many years without any adverse effects. However, Dr. Swerdlow stated in a study in 2002 concerning 1,800 individuals that were given human growth hormone therapy that there risk for colorectal cancer and Hodgkin’s Disease increased. On the other hand, this statement had nothing to warrant that it was the human growth hormone that was the root cause of possibly developing cancer.
Safety Through Clinical Studies
Dr. Cook explained that IGF-1 is naturally produced or created by our bodies, this agent when it becomes in excess has been seen in disorders such as acromegaly, however, it has not been associated with an increase in any type of cancer. As quoted by Dr. Cook, “high-normal IGF-1 concentrations may be a marker for cancer but are not causally related to inducement or growth of cancer.” He explained further in his report that, that “appropriate growth hormone replacement therapy is associated with normalization, not elevation, of serum IGF-1 concentrations. In addition, levels of binding proteins are increased with growth hormone replacement, along with levels of IGF-1, resulting in normal, not elevated, free IGF-1 concentrations.”
Marc R. Blackman, M.D. reported in the November 13, 2002 issue of the Journal of the American Medical Association that during his study with investigators from the National Institute on Aging, Intramural Research Program and investigators from the Johns Hopkins University School of Medicine in Baltimore that “side effects went away after the hormone treatment was discontinued.”
No studies and clinical trials of human growth hormone can attest to any damage or even side effects that cannot be corrected with lower dosages of the injectable HGH.